186 related articles for article (PubMed ID: 2269381)
41. [General and local hormonal therapy in scleroderma].
Dobrescu A; Petrescu Z; Martinescu E; Costinescu M; Vasilca A; Popescu E; Rotaru L; Tăranu T; Pavelescu DM
Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):145-9. PubMed ID: 3393746
[No Abstract] [Full Text] [Related]
42. [Low-molecular dextran (40,000) in the treatment of scleroderma].
Szczepański A; Zielińska Z; Polkowska M; Lorenc B
Przegl Dermatol; 1975; 62(1):79-82. PubMed ID: 1111035
[No Abstract] [Full Text] [Related]
43. [Madecassol in the treatment of scleroderma (preliminary study)].
Szczepański A; Dabrowska H; Blaszczyk M
Przegl Dermatol; 1974; 61(5):701-3. PubMed ID: 4419170
[No Abstract] [Full Text] [Related]
44. Iloprost for scleroderma.
Constans T; Diot E; Lasfargues G
Ann Intern Med; 1991 Apr; 114(7):606. PubMed ID: 1705762
[No Abstract] [Full Text] [Related]
45. Cellular infiltrates in scleroderma skin.
Fleischmajer R; Perlish JS; Reeves JR
Arthritis Rheum; 1977 May; 20(4):975-84. PubMed ID: 861067
[TBL] [Abstract][Full Text] [Related]
46. Skin collagen from scleroderma patients before and after cyclosporin A treatment.
Francès C; Branchet MC; Blétry O; Lefevre C; Boisnic S; Kern P; Godeau P
Clin Exp Dermatol; 1988 Jan; 13(1):1-3. PubMed ID: 3208433
[No Abstract] [Full Text] [Related]
47. [Trafuril reaction in scleroderma].
Urban J
Przegl Dermatol; 1976; (6 Suppl):367-9. PubMed ID: 1032188
[No Abstract] [Full Text] [Related]
48. Cyclosporine therapy for severe systemic sclerosis associated with the anti-Scl-70 autoantibody.
Vayssairat M; Baudot N; Boitard C; Fiessinger JN; Bach JF
J Am Acad Dermatol; 1990 Apr; 22(4):695-6. PubMed ID: 2319032
[No Abstract] [Full Text] [Related]
49. Oral calcitriol as a new therapeutic agent in localized and systemic scleroderma.
Humbert P; Aubin F; Dupond JL; Delaporte E
Arch Dermatol; 1995 Jul; 131(7):850-1. PubMed ID: 7611809
[No Abstract] [Full Text] [Related]
50. Cyclosporine: therapeutic effects in rheumatic diseases.
Amor B; Dougados M
Transplant Proc; 1988 Jun; 20(3 Suppl 4):218-23. PubMed ID: 3289207
[No Abstract] [Full Text] [Related]
51. Iloprost as cyclic five-day infusions in the treatment of scleroderma. An open pilot study in 20 patients treated for one year.
Biasi D; Carletto A; Caramaschi P; Zeminian S; Pacor ML; Corrocher R; Bambara LM
Rev Rhum Engl Ed; 1998 Dec; 65(12):745-50. PubMed ID: 9923042
[TBL] [Abstract][Full Text] [Related]
52. Scleroderma.
Asboe-Hansen G
J Am Acad Dermatol; 1987 Jul; 17(1):102-8. PubMed ID: 3611439
[TBL] [Abstract][Full Text] [Related]
53. Systemic sclerosis and localized scleroderma in childhood.
Zulian F
Rheum Dis Clin North Am; 2008 Feb; 34(1):239-55; ix. PubMed ID: 18329543
[TBL] [Abstract][Full Text] [Related]
54. [The course of scleroderma following treatment with carnitin].
Nitzschner H
Dermatol Monatsschr; 1974 Jul; 160(7):592-6. PubMed ID: 4411133
[No Abstract] [Full Text] [Related]
55. Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis.
Falanga V; Medsger TA
J Am Acad Dermatol; 1987 Oct; 17(4):648-56. PubMed ID: 3668010
[TBL] [Abstract][Full Text] [Related]
56. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
[TBL] [Abstract][Full Text] [Related]
57. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
Sych LI; Trofimova LIa
Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
[No Abstract] [Full Text] [Related]
58. Cyclosporin A in progressive systemic sclerosis.
Yocum DE; Wilder RL
Am J Med; 1987 Aug; 83(2):369-70. PubMed ID: 3618643
[No Abstract] [Full Text] [Related]
59. [Scleroderma in children].
Frati Munari AC; Culebro Nieves G; Velázquez E; Podoswa G
Bol Med Hosp Infant Mex; 1979; 36(2):201-14. PubMed ID: 758191
[TBL] [Abstract][Full Text] [Related]
60. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma].
Didenko IG
Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
